VIVA BIOTECH (01873) spent 404,500 Hong Kong dollars to repurchase 450,000 shares on November 15th.
Viva Biotech (01873) announced that the company spent 404,500 Hong Kong dollars on November 15, 2024...
VIVA BIOTECH (01873) announces that the company has repurchased 450,000 shares on November 15, 2024, at a total cost of 404,500 Hong Kong dollars, with a repurchase price per share ranging from 0.89 to 0.9 Hong Kong dollars.
Related Articles
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Huiyu Pharmaceutical (688553.SH) subsidiary's clinical trial application for injection HY07121 (subcutaneous injection) has been accepted.
Hangzhou Haoyue Personal Care (605009.SH) plans to invest up to 20 million US dollars to establish an overseas subsidiary in Egypt and build a production base.
Tasly Pharmaceutical Group's subsidiary has obtained the registration certificate for bosentan dispersible tablets.
Huiyu Pharmaceutical (688553.SH) subsidiary's clinical trial application for injection HY07121 (subcutaneous injection) has been accepted.
Hangzhou Haoyue Personal Care (605009.SH) plans to invest up to 20 million US dollars to establish an overseas subsidiary in Egypt and build a production base.
RECOMMEND
